​
​

Carmell Therapeutics Stock (NASDAQ:CTCXW)

RevenueOwnershipFinancialsChart
Carmell Therapeutics by TradingView

Previous Close

$0.09

52W Range

$0.12 - $0.13

50D Avg

-

200D Avg

-

Market Cap

$11.20M

Avg Vol (3M)

-

Beta

-

Div Yield

-

CTCXW Company Profile

Show More

Industry

-

Sector

-

Exchange

NASDAQ

ADR

-

Country

-

Employees

-

IPO Date

-

Website

-

CTCXW Performance

CTCXW Financial Summary

Dec 23Dec 22Dec 21
Revenue---
Operating Income$-5.22M$-5.51M$-1.94M
Net Income$-15.45M$-9.05M$-6.48M
EBITDA$-5.09M$-5.25M$-1.66M
Basic EPS$-1.40$-0.46$-0.33
Diluted EPS$-1.40$-0.46$-0.33

Fiscal year ends in Dec 23 | Currency in USD